-
News
- Technology /AI
- Medical journals
- Topics
Iron Deficiency and Anemia
We recommend
Iron Deficiency and Administration of Ferric Carboxymaltose in Patients with Heart Failure
21. 6. 2022 Source: Iron Deficiency and AnemiaIron deficiency is very common in patients with heart failure and is associated with exercise intolerance, reduced quality of life, increased mortality, and higher risk of hospitalization, regardless of the presence of anemia. Clinical studies have previously demonstrated the positive effect of intravenous administration of ferric carboxymaltose (FCM) in patients with chronic heart failure with reduced ejection fraction of the left ventricle. The AFFIRM-AHF study investigated the effect of FCM administration initiated shortly before…
Effect of Administering Ferric Carboxymaltose on Quality of Life in Heart Failure Patients
The quality of life in patients with heart failure is significantly reduced. The concurrent…7. 2. 2022 Source: Iron Deficiency and Anemia
Importance of Testing for Iron Deficiency in Patients with Chronic Heart Failure and Treatment Options
Intravenous iron application in patients with heart failure and iron deficiency is now part of ESC…5. 10. 2021 Source: Iron Deficiency and Anemia
No content is currently available on this topic.LoginSubscribe
Most read on this topic- Iron Deficiency and Administration of Ferric Carboxymaltose in Patients with Heart Failure
- Importance of Testing for Iron Deficiency in Patients with Chronic Heart Failure and Treatment Options
- Effect of Administering Ferric Carboxymaltose on Quality of Life in Heart Failure Patients
Related topicLogin#ADS_BOTTOM_SCRIPTS#Forgotten passwordEnter the email address that you registered with. We will send you instructions on how to set a new password.
- Technology /AI